We are live on ! Find out more
DCM

DME Capital Management Portfolio holdings

AUM $3.19B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+23.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.85B
AUM Growth
+$308M
Cap. Flow
+$334M
Cap. Flow %
11.71%
Top 10 Hldgs %
65.06%
Holding
45
New
8
Increased
11
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
GPK icon
Graphic Packaging
GPK
+$61M
2
CPRI icon
Capri Holdings
CPRI
+$48.1M
3
ACHC icon
Acadia Healthcare
ACHC
+$46.9M
4
CNC icon
Centene
CNC
+$40.4M
5
SPB icon
Spectrum Brands
SPB
+$37.3M

Top Sells

Rank Stock Value
1
SDRL icon
Seadrill
SDRL
+$48M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$17.7M
3
WFRD icon
Weatherford International
WFRD
+$15.8M
4
NXST icon
Nexstar Media Group
NXST
+$14.6M
5
KD icon
Kyndryl
KD
+$14.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.66%
2 Healthcare 14.27%
3 Energy 14.18%
4 Industrials 10.82%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DECK icon
26
Deckers Outdoor
DECK
$13.2B
$31M 1.09%
+298,778
New +$28M
CI icon
27
Cigna
CI
$73.7B
$25.8M 0.91%
93,750
– –
SLDE
28
Slide Insurance Holdings
SLDE
$2.33B
$22.4M 0.79%
+1,149,880
New +$19.2M
PRKS icon
29
United Parks & Resorts
PRKS
$2.1B
$20.9M 0.73%
574,620
+103,570
+22% +$4.3M
LKFT
30
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$15.8M 0.55%
482,746
– –
COYA icon
31
Coya Therapeutics
COYA
$98.3M
$11.8M 0.41%
2,025,940
+379,500
+23% +$2.31M
SNX icon
32
TD Synnex
SNX
$20.4B
$8.49M 0.3%
56,490
+17,460
+45% +$2.68M
SHC icon
33
Sotera Health
SHC
$5.09B
$8.14M 0.29%
461,270
+280,690
+155% +$4.64M
GDX icon
34
VanEck Gold Miners ETF
GDX
$23.2B
$5.57M 0.2%
64,960
-11,500
-15% -$908K
KWEB icon
35
KraneShares CSI China Internet ETF
KWEB
$5.69B
$4.48M 0.16%
131,510
+45,140
+52% +$1.74M
GPRO icon
36
GoPro
GPRO
$130M
$2.39M 0.08%
1,693,860
– –
GANX icon
37
Gain Therapeutics
GANX
$71.7M
$1.82M 0.06%
566,130
– –
PTON icon
38
Peloton Interactive
PTON
$2.77B
$1.52M 0.05%
246,460
– –
NUVB icon
39
Nuvation Bio
NUVB
$2.2B
$314K 0.01%
34,995
– –
NUVB.WS
40
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$33K ﹤0.01%
100,000
– –
KPLTW
41
DELISTED
Katapult Holdings Warrant
KPLTW
$944 ﹤0.01%
262,227
– –
HPQ icon
42
HP
HPQ
$24.9B
– –
-300,000
Closed -$8.17M
NXST icon
43
Nexstar Media Group
NXST
$5.82B
– –
-73,940
Closed -$14.6M
OIH icon
44
VanEck Oil Services ETF
OIH
$1.89B
– –
-12,360
Closed -$3.21M
SDRL icon
45
Seadrill
SDRL
$2.8B
– –
-1,588,828
Closed -$48M
1
2

Similar funds

MPW
MASECO Private Wealth London $3.19B AUM 14.06% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.2B AUM 32.2% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

DME Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, DME Capital Management held 45 positions worth $2.85B, up 12% from $2.54B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

DME Capital Management deployed $334M of net new capital in Q4 2025, opening 8 new positions and adding to 11 existing holdings. Its largest new stake was Spectrum Brands: 663,890 shares worth $39.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 41% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $17.7M trimmed.

  • DME Capital Management's largest Q4 2025 buy was Spectrum Brands: 663,890 shares worth $39.2M.
  • DME Capital Management added most to Graphic Packaging in Q4 2025, an estimated $61M increase.
  • DME Capital Management's biggest Q4 2025 reduction was Teva Pharmaceuticals, cutting an estimated $17.7M.
  • DME Capital Management fully exited Seadrill in Q4 2025, selling an estimated $48M.
  • DME Capital Management's ten largest holdings make up 65% of its $2.85B portfolio in Q4 2025.
  • DME Capital Management opened 8 new positions and closed 4 in Q4 2025.
  • DME Capital Management's portfolio value rose 12% quarter-over-quarter to $2.85B.

Based on DME Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.